Dr. James Megehee, M.D. Pathology - Clinical Pathology/Laboratory Medicine Medicare: Not Enrolled in Medicare Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-809-5000 |
Dr. Gordon Gaethe, M.D. Pathology - Clinical Pathology/Laboratory Medicine Medicare: Not Enrolled in Medicare Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-809-5000 |
Dr. Karin Levesque, M.D. Pathology - Clinical Pathology/Laboratory Medicine Medicare: Not Enrolled in Medicare Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-809-5000 |
Dr. Victor Calcote, M.D. Pathology - Clinical Pathology/Laboratory Medicine Medicare: Medicare Enrolled Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-809-5000 |
Dr. Sidney Eudy, M.D. Pathology - Clinical Pathology/Laboratory Medicine Medicare: Not Enrolled in Medicare Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-809-5000 |
Lacey Sullivan, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-818-6063 Fax: 228-809-2254 |
News Archive
Scientists have made an important advance in understanding how a subset of bacterial cells escape being killed by many antibiotics.
In particularly aggressive forms of breast cancer, cancer cells can settle in other organs and form metastases there. Once such metastases form, complete recovery is rare. Consequently, it is enormously important to prevent the metastasisation of the breast cancer cells. The success, however, achieved by using existing forms of therapy is limited.
The stimulant drug methylphenidate "normalizes" activation of several brain areas in young patients with attention-deficit/hyperactivity disorder (ADHD), according to a review published in the May Harvard Review of Psychiatry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
SAS, the leader in business analytics software and services, and GE Healthcare have entered into a joint development and marketing agreement by which GE Healthcare will leverage SAS technology to analyze and deliver relevant, detailed patient safety information to help hospitals address preventable adverse medical events.
Many EPA programs make decisions on regulation of metals, particularly controlling releases to the environment and establishing acceptable levels in air, water, or land.
› Verified 1 days ago